Prognostic significance of the CD10+CD19+CD34+ B-Progenitor immunophenotype in children with acute lymphoblastic leukemia: A report from the Children's Cancer Group

Leukemia and Lymphoma

Volumn 27, Issue 5-6, 1997, Pages 445-457

  Uckun, Faith M ^a,b   Sather, Harland ⁱ   Gaynon, Paul ^c   Arthur, Diane ^a,b   Nachman, James ^d   Sensel, Martha ^j   Steinherz, Peter ^g   Hutchinson, Raymond ^e   Trigg, Michael ^f   Reaman, Gregory ^h  

^a University of Minnesota   (United States)

^b PARKER HUGHES INSTITUTE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

ⁱ S California ^*  (United States)

^j CHILDREN S ONCOLOGY GROUP   (United States)

more..

Author keywords

Acute lymphoblastic leukemia; B progenitor immunophenotype; CD10+ CD19+ CD34+ ALL; Children; Prognosis

Indexed keywords

CD19 ANTIGEN; CD34 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILDHOOD LEUKEMIA; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA CELL; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 6844258219     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709058311     Document Type: Article

References (41)

1. Korsmeyer, S. J. (1987). Antigen receptor genes as molecular markers of lymphoid neoplasms. J Clin Invest, 79, 1291-1295.
2. Nadler, L. M., Korsmeyer, S. J., Anderson, K. C., et al (1984), B-cell origin of non-T-cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B-cell differentiation. J Clin Invest, 74, 332-340.
3. Pui, C. H., Behm, F. G. and Crist, W. M. (1993). Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood, 82, 343-362.
4. Uckun, F. M. (1990). Regulation of human B-cell ontogeny. Blood, 76, 1908-1923.
5. Champlin, R. and Gale, R. P. (1989). Acute lymphoblastic leukemia: recent advances in biology and therapy [see comments]. Blood, 73, 2051-2066.
6. Greaves, M. F. (1986). Differentiation-linked leukemogenesis in lymphocytes. Science, 234, 697-704.
7. Chen, J., Alt, F. W. (1993). Gene rearrangement and B-cell development. Curr Opin Immunol, 5, 194-200.
8. Fanning, L. J., Connor, A. M. and Wu, G. E. (1996). Development of the immunoglobulin repertoire. Clin Immunol Immunopathol, 79, 1-14.
9. Hentges, F. (1994). B lymphocyte ontogeny and immunoglobulin production. Clin Exp Immunol, 97 Suppl 1, 3-9.
10. Schroeder, H. W., Jr., Mortari, F., Shiokawa, S. et al. (1995). Developmental regulation of the human antibody repertoire. Ann N Y Acad Sci, 764, 242-260.
11. Crist, W., Boyett, J., Roper, M., et al. (1984). Pre-B-cell leukemia responds poorly to treatment: a pediatric oncology group study. Blood, 63, 407-414.
12. Crist, W., Boyett, J., Jackson, J., et al. (1989) Prognostic importance of the pre-B-cell immunophenotype and other presenting features in B-lineage childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood, 74, 1252-1259.
13. Borowitz, M. J., Shuster, J. J., Civin, C. I., et al. (1990). Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study. J Clin Oncol, 8, 1389-1398.
14. Civin, C. I., Banquerigo, M. L., Strauss, L. C., et al. (1987). Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow. Exp Hematol, 15, 10-7.
15. Hurwitz, C. A., Loken, M. R. and Graham, M. L., et al. (1988). Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. Blood, 72, 299-307.
16. Loken, M. R., Shah, V. O., Dattilio, K. L., et al. (1987). Flow cytometric analysis of human hone marrow. II. Normal B-lymphocyte development. Blood, 70, 1316-1324.
17. Pontvert Delucq, S., Breton Gorius, J., Schmitt, C., et al. (1993). Characterization and functional analysis of adult human bone marrow cell subsets in relation to B-lymphoid development. Blood, 82, 417-429.
18. Ryan, D., Kossover, S., Mitchell, S., et al. (1986). Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens. Blood, 68, 417-425.
19. Steinherz, P. G., Gaynon, P., Miller, D. R., et al. (1986). Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen-a new intensive therapy protocol: a report from the Childrens Cancer Study Group. J Clin Oncol, 4, 744-752.
20. Tubergen, D., Gilchrist, G., O'Brien, A., et al. (1993). Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features. J Clin Oncol, 11, 527-537.
21. Gaynon, P. S., Steinherz, P. G., Bleyer, W. A., et al. (1988). Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study Group. Lancet, 2, 921-924.
22. Steinherz, P. G., Siegel, S. E., Bleyer, W. A., et al. (1991). Lymphomatous presentation of childhood acute lymphoblastic leukemia. Cancer. 68, 751-758.
23. Smith, M., Arthur, D., Camitta, B., et al. (1996). Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia [see comments]. J Clin Oncol, 14, 18-24.
24. + acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Blood, 73, 1000-1015.
25. Uckun, F. M., Gajl Peczalska, K. J., Provisor, A. J., et al. (1989). Immunophenotype-karyotype associations in human acute lymphoblastic leukemia. Blood, 73, 271-280.
26. Uckun, F. M. and Ledbetter, J. A. (1988). Immunobiologic differences between normal and leukemic human B-cell precursors. Proc Natl Acad Sci U S A. 85, 8603-8607.
27. Hollander, M. and Wolfe, D. (1973). Nonparametric Statistical Methods. (John Wiley & Sons. New York), pp 115-120.
28. Kaplan, E. and Meier, P. (1958). Nonparametric estimation from incomplete observations. J Am Stat. Assoc, 53, 457-481.
29. Mantel, N. (1966). Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep, 50, 163-170.
30. Peto, R., Pike, M. C., Armitage, P., et al. (1977). Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II. Analysis and examples. Br J Cancer, 35, 1-.
31. Cox, D. R. (1972). Regression models and life tables. Royal Stat Soc B, 34, 187-220.
32. Breslow, N. (1975). Analysis of survival data under the proportional hazards model, Int Stat Rev, 43, 45-58.
33. Basso, G., Rondelli, R., Covezzoli, A., et al., (1994). The role of immunophenotype in acute lymphoblastic leukemia of infant age. Leak Lymphoma, 15, 51-60.
34. Crist, W., Pullen, J., Boyett, J., et al. (1986). Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: a Pediatric Oncology Group Study. Blood, 67, 135-140.
35. Pieters, R., Kaspers, G. J., van Wering, E. R., et al. (1993). Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia. Leukemia, 7, 392-397.
36. Pui, C. H., Rivera, G. K., Hancock, M. L., et al. (1993). Clinical significance of CD10 expression in childhood acute lymphoblastic leukemia. Leukemia, 7, 35-40.
37. Pui, C. H., Hancock, M. L., Head, D. R., et al. Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia. Blood, 82, 889-894.
38. Ishii, E., Okamura, J., Tsuchida, M., et al. (1991). Infant leukemia in Japan: clinical and biological analysis of 48 cases. Medical And Pediatric Oncology, 19, 28-32.
39. Ludwig, W. D., Bartram, C. R., Harbott, J., et al. (1989). Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia. Leukemia, 3, 431-439.
40. Pui, C. H., Raimondi, S. C., Murphy, S. B., et al. (1987). An analysis of leukemic cell chromosomal features in infants. Blood, 69, 1289-1293.
41. Vogler, L. B., Crist, W. M., Bockman, D. E., et al. (1978). Pre-B-Cell leukemia, a new phenotype of childhood lymphoblastic Leukemia. New England Journal Of Medicine. [Overseas Edition] 298, 872-878.